← Eichor
Study identifier: NCT06209047 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis

Condition: Bronchiectasis With Acute Exacerbation  ·  Sponsor: Assiut University

PhasePhase 4
Planned participants315
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Randomized single-center trial evaluating whether bronchoscopic instillation of levofloxacin or gentamicin improves outcomes compared to a sham bronchoscopic procedure in adult ICU patients with non-cystic fibrosis bronchiectasis requiring invasive mechanical ventilation. The primary outcome is a ranked composite of in-hospital mortality and time to ventilator liberation. Safety and procedural adverse events are closely monitored.

This description comes directly from the study's public registry record.

Talk to the study team

Ali A Ali, MSc  ·  +2001064756136  ·  aliabuzaid@aun.edu.eg

Ahmad M shaddad, MD  ·  +2001111171930  ·  Shaddad_ahmad@aun.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Assiut university hospitalsAsyut, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06209047